Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study
Academic Article
Publication Date:
2022
Short description:
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study / De Vito, A., Poliseno, M., Colpani, A., Zauli, B., Puci, M.V., Santantonio, T., Meloni, M.C., Fois, M., Fanelli, C., Saderi, L., Fois, A., Fiore, V., Sotgiu, G., Babudieri, S., Lo Caputo, S., Madeddu, G.. - In: CURRENT MEDICAL RESEARCH AND OPINION. - ISSN 0300-7995. - (2022), pp. 1-15. [10.1080/03007995.2022.2129801]
abstract:
Since the start of the SARS-CoV-2 pandemic, several treatment options have been proposed (e.g. steroids, heparin, antivirals, and monoclonal antibodies). Remdesivir was the first antiviral approved for the treatment of COVID-19, even though controversial evidence exists concerning the efficacy. Therefore, we aimed to conduct a study to evaluate if the use of remdesivir was associated with lower mortality in patients with COVID-19.
Iris type:
1.1 Articolo in rivista
Keywords:
COVID-19; COVID-19 treatment; Italy; SARS-CoV-2; antiviral; case-control study; mortality; remdesivir
List of contributors:
De Vito, Andrea; Poliseno, Mariacristina; Colpani, Agnese; Zauli, Beatrice; Puci, Mariangela Valentina; Santantonio, Teresa; Meloni, Maria Chiara; Fois, Marco; Fanelli, Chiara; Saderi, Laura; Fois, Alessandro; Fiore, Vito; Sotgiu, Giovanni; Babudieri, Sergio; Lo Caputo, Sergio; Madeddu, Giordano
Published in: